Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia-Reference-Cited by-同舟云学术

Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia

Published:2019-11-26 Issue:4 Volume:68 Page:699-707
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J Am Geriatr Soc

Author:

Niznik Joshua D.¹²^ORCID,Zhao Xinhua²³,He Meiqi³,Aspinall Sherrie L.²³⁴^ORCID,Hanlon Joseph T.²⁵,Hanson Laura C.¹,Nace David⁵^ORCID,Thorpe Joshua M.²⁶,Thorpe Carolyn T.²⁶

Affiliation:

1. University of North Carolina School of Medicine Division of Geriatric Medicine Chapel Hill North Carolina

2. VA Pittsburgh Healthcare System Center for Health Equity Research and Promotion Pittsburgh Pennsylvania

3. University of Pittsburgh School of Pharmacy Pittsburgh Pennsylvania

4. VA Center for Medication Safety Hines Illinois

5. University of Pittsburgh School of Medicine Geriatric Division Pittsburgh Pennsylvania

6. University of North Carolina Eshelman School of Pharmacy Chapel Hill North Carolina

Funder

National Institute on Aging

Patrick and Catherine Weldon Donaghue Medical Research Foundation

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgs.16241

Reference46 articles.

1. A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence

2. Cholinesterase Inhibitor and N-Methyl-D-Aspartic Acid Receptor Antagonist Use in Older Adults with End-Stage Dementia: A Survey of Hospice Medical Directors

3. When do we discontinue anti-dementia drugs? Views expressed by clinicians in a national survey within the United Kingdom

4. Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts

5. The influence and changes in the dosages of concomitantly used psychotropic drugs associated with the discontinuation of donepezil in severe Alzheimer’s disease with behavioral and psychological symptoms on dementia: a preliminary open-label trial

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application and content of minimum data sets for care homes: A mapping review;2024-06-24

2. A comparison of dementia diagnoses and cognitive function measures in Medicare claims and the Minimum Data Set;Journal of the American Geriatrics Society;2024-05-30

3. Validating claims‐based definitions for deprescribing: Bridging the gap between clinical and administrative data;Pharmacoepidemiology and Drug Safety;2024-03-31

4. Anti-dementia drugs: what is the evidence in advanced stages?;Porto Biomedical Journal;2024-03

5. The risk of bone fractures in dementia patients receiving acetylcholinesterase inhibitors: a meta-analysis;Annals of Medicine & Surgery;2024-01-15